Home Applications 206426 Application 206426
Type NDA
Sponsor BIOCRYST Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 RAPIVAB PERAMIVIR SOLUTION;INTRAVENOUS 200MG/20ML (10MG/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206426-001 RAPIVAB PERAMIVIR 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206426-001 10391075 2027-02-12 U-2622 2019-09-25 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 N206426-001 8778997 2027-05-07 U-3069 2015-01-13
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N206426-001 RAPIVAB 200MG/20ML (10MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2014-12-19 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 6 · 215 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206426-001 10391075 2027-02-12 U-2622 2019-09-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206426-001 10391075 2027-02-12 U-3069 2019-09-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206426-001 8778997 2027-05-07 U-2622 2015-01-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206426-001 8778997 2027-05-07 U-1627 2015-01-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206426-001 8778997 2027-05-07 U-3069 2015-01-13 5bbf6a4d5a75…
Observed Orange Book exclusivity history# NDC Listings For This Application# NDC listings for this application page 1 of 1 · 5 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 61364-181 Rapivab peramivir Seqirus USA Inc. NDA Current 61364-181 Rapivab peramivir Seqirus USA Inc. NDA Current 72769-181 Rapivab peramivir BioCryst Pharmaceuticals, Inc. NDA Current 72769-181 Rapivab peramivir BioCryst Pharmaceuticals, Inc. NDA Current 72769-181 Rapivab peramivir BioCryst Pharmaceuticals, Inc. NDA Current